Drug Trial Radar · NCT05840822
Evaluating Efficacy and Safety of CBD TPM Capsules for Use in Insomnia
Last checked: Nov 20, 2026Latest source record: Jun 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
519
Planned (sponsor's estimate)
Start
May 16, 2024
Primary completion
Sep 30, 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Avecho BiotechnologyIndustry
- Sponsor type
- Industry
- First posted
- May 3, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Insomnia is a common sleep disorder in which a person has difficulty falling asleep or staying asleep or getting good quality sleep. Consequences of insomnia include daytime sleepiness, poor memory function, decline in concentration with negative impacts on social and work activities. Although medical cannabis and cannabis products are widely used worldwide for the management of symptoms associated with insomnia, there is little clinical data available to support the efficacy or utility of CBD in the management of sleep disorders. The proposed study will assess whether nightly doses of 75mg or 150mg of an 8 week period are able to improve patient reported sleep quality when compared to a placebo.
Conditions
- Insomnia
Interventions
Cannabidiol (CBD) Capsule 75mgDrug
Cannabidiol (CBD) capsule containing 75mg CBD
PlaceboDrug
Placebo capsule without cannabidiol
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean change from study baseline of insomnia severity index (ISI) score at 8 weeksTime frame: 8 weeks
- Mean change from study baseline in subject sleep efficiency (sSE) at 8 weeksTime frame: 8 weeks
Locations
5 sites in 1 country. Site status is shown where the registry gives one.
Pioneer Clinical Research
North Sydney, New South Wales, Australia
Key Health, CBD South
Sydney, New South Wales, Australia
Griffith University
Southport, Queensland, Australia
Monash Health
Clayton, Victoria, Australia
Captain Stirling Medical Centre
Nedlands, Western Australia, Australia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.